iNodes against ovarian cancer (IMAGE)
Caption
Driven by the urgent need for new therapies to treat cancers that specifically affect women, Girija Goyal, who is the Principal Investigator on the ARPA-H project, together with a team at the Wyss Institute develops “iNodes,” the first implantable immune organs to help prolong the lives of patients with advanced ovarian cancer.
Credit
Wyss Institute at Harvard University
Usage Restrictions
None
License
Original content